KF005-CITE-seq

Assay Information

Assay Name: KF005-CITE-seq

Study: EXP2

Investigation: Katia - COVID vaccinated SLE individuals

Assay Type: CITE-seq

Sequencing Platform: Illumina NovaSeq 6000

Pipeline Version: Not specified

Run Date: 2024-05-28

Samples (6)
Quality Status: Track quality control results for each sample in this assay. Pending = awaiting review, Passed = meets QC criteria, Failed = below QC thresholds, Flagged = needs attention. Click the dropdown to update status.
Sample Name Position Barcode Quality Status Cell Type Condition Actions
KF005-HTC1 Click to set SI-TT-B5 PE enriched SARS-CoV-2 Spike+ B cells SLE
View
KF005-HTC2 Click to set SI-TT-B5 PE enriched SARS-CoV-2 Spike+ B cells SLE
View
KF005-HTC3 Click to set SI-TT-B5 PE enriched SARS-CoV-2 Spike+ B cells SLE
View
KF005-HTC4 Click to set SI-TT-B5 PE enriched SARS-CoV-2 Spike+ B cells SLE
View
KF005-HTC5 Click to set SI-TT-B5 PE enriched SARS-CoV-2 Spike+ B cells SLE
View
KF005-HTC6 Click to set SI-TT-B5 PE enriched SARS-CoV-2 Spike+ B cells SLE
View
Assay Timeline
Created:
2025-09-03 14:21 UTC
Run Date:
2024-05-28
Last Updated:
2025-11-20 16:53 UTC
Assay Statistics

6

Total Samples
6 Pending
Quick Actions
Edit Assay View Study